Page last updated: 2024-11-02

piracetam and Carcinoma, Squamous Cell

piracetam has been researched along with Carcinoma, Squamous Cell in 1 studies

Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.

Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)

Research Excerpts

ExcerptRelevanceReference
"Initial seizure control with enteral levetiracetam was achieved, and when enteral and intravenous (i."5.43Continuous subcutaneous levetiracetam in the management of seizures at the end of life: a case report. ( Chambers, J; Foreman, E; Mason, LD; Wells, GH, 2016)
"Initial seizure control with enteral levetiracetam was achieved, and when enteral and intravenous (i."1.43Continuous subcutaneous levetiracetam in the management of seizures at the end of life: a case report. ( Chambers, J; Foreman, E; Mason, LD; Wells, GH, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wells, GH1
Mason, LD1
Foreman, E1
Chambers, J1

Other Studies

1 other study available for piracetam and Carcinoma, Squamous Cell

ArticleYear
Continuous subcutaneous levetiracetam in the management of seizures at the end of life: a case report.
    Age and ageing, 2016, Volume: 45, Issue:2

    Topics: Aged, 80 and over; Anticonvulsants; Brain Neoplasms; Carcinoma, Squamous Cell; Head and Neck Neoplas

2016